
    
      SAD part:

      A total of 3 weeks dosing, the two lowest concentrations in week 1, dose 3 at week 2 and
      finally dose 4 at week 3.

      MD part:

      In total 12 weeks of dosing where group A will be dosed twice weekly and group B three times
      weekly

      Each injection will be administered into one of five of the six randomized areas (10 cm
      apart, left and right side) from the subject's defined investigational skin areas. One area
      will be completely untreated.
    
  